TrialJournal of the American Society of Nephrology : JASN2007

Sustained, long-term renal stabilization after 54 months of agalsidase beta therapy in patients with Fabry disease.

Dominique P Germain et al.PubMed ↗Publisher ↗

No numbers read from the abstract.